Literature DB >> 31574452

LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.

Yiqing Liu1, Li Xu2, Bingru Lu1, Miaoqing Zhao3, Li Li1, Wenping Sun1, Zhanjun Qiu4, Bingchang Zhang5.   

Abstract

Emerging evidence indicates that the lncRNAs/microRNA/mRNA axis plays important roles in a variety of diseases. This study was aimed to investigate the potential roles and underlying molecular mechanisms of lncRNA H19 and H19-derived miR-675 in regulating hepatitis B virus (HBV)-associated liver injury. mRNA and miR-675 levels were determined by quantitative real-time PCR (qRT-PCR), protein levels were determined by western blot, cell viability was measured by the MTT assay, cell apoptosis was measured by flow cytometry, inflammatory cytokine production was determined by ELISA, oxidative stress and energy metabolism were assessed by commercial kits, and the target relationship between PPARα and miR-675 was confirmed by the dual-luciferase reporter assay. The results showed that the expression of lncRNA H19 and miR-675 was up-regulated in patients with chronic hepatitis B (n = 20). Inhibition of lncRNA H19 or miR-675 in L02 cells increased cell viability, suppressed hepatitis B X protein (HBx)-induced cell apoptosis, inflammatory cytokine production, and oxidative stress, and remodelled energy metabolism. Furthermore, PPARα was found to be a target gene of miR-675. The expression of PPARα was down-regulated in patients with chronic hepatitis B, and there was a negative correlation between the expression of lncRNA H19 and PPARα, or between miR-675 and PPARα. Moreover, by knocking down the expression of PPARα, the actions (apoptosis, inflammatory factors, oxidative stress, and energy metabolism) of lncRNA H19 or miR-675 inhibition in HBx-induced L02 cells were at least partially reversed. In addition, HBx-induced elevated levels of p-AktSer473, p-AktThr308 and p-mTORSer2448 were down-regulated by lncRNA H19 or miR-675 inhibition. Furthermore, PPARα knockdown partly reversed the down-regulated effects of H19 or miR-675 inhibition. Taken together, these data indicate that the lncRNA H19/miR-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by HBx, which may be related to the modulation of Akt/mTOR signalling.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Akt/mTOR signalling; HBx; Liver cell injury; PPARα; lncRNA H19; miR-675

Year:  2019        PMID: 31574452     DOI: 10.1016/j.molimm.2019.09.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Li Wang
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

Review 2.  Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases.

Authors:  Zhihong Yang; Ting Zhang; Sen Han; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2020-11-20       Impact factor: 10.171

3.  lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR‑495‑3p/MYCBP axis.

Authors:  Jiajie Qian; Alok Garg; Fuqiang Li; Qianyun Shen; Ke Xiao
Journal:  Int J Oncol       Date:  2020-09-25       Impact factor: 5.650

Review 4.  Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer.

Authors:  Xueke Wang; Meisong Kang; Chun Liu; Ting Lin; Xiao Han; Xiwen Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-18       Impact factor: 5.293

Review 5.  Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma.

Authors:  Nazia Samudh; Creanne Shrilall; Patrick Arbuthnot; Kristie Bloom; Abdullah Ely
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

6.  Screening and preliminary identification of long non-coding RNAs critical for osteogenic differentiation of human umbilical cord mesenchymal stem cells.

Authors:  Xiao Zheng; Shuaiqi Gan; Cheng Su; Zheng Zheng; Yihan Liao; Jingjing Shao; Zhimin Zhu; Wenchuan Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 7.  Long noncoding RNAs in hepatitis B virus replication and oncogenesis.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

8.  Molecular characterization of metabolic subtypes of gastric cancer based on metabolism-related lncRNA.

Authors:  Lingdi Li; Jianfei Ma
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

9.  Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis.

Authors:  Yi He; Yingzhi Zhou; Huimin Wang; Jingyang Yin; Yunan Chang; Peng Hu; Hong Ren; Hongmei Xu
Journal:  J Cell Mol Med       Date:  2021-05-26       Impact factor: 5.310

Review 10.  Role of alcohol in pathogenesis of hepatitis B virus infection.

Authors:  Murali Ganesan; Allison Eikenberry; Larisa Y Poluektova; Kusum K Kharbanda; Natalia A Osna
Journal:  World J Gastroenterol       Date:  2020-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.